Skip to main content
Clinical Trials/IRCT20210617051604N1
IRCT20210617051604N1
Recruiting
Phase 3

Evaluation of the effects of vitamin E on the treatment and prevention of relapse in women with lower urinary tract infection

Birjand University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Birjand University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women over 18 years
  • At least three symptoms including frequency, urgency (urgent need to urinate), dysuria, hematuria, and suprapubic pain

Exclusion Criteria

  • History of allergy or intolerance to vitamin E
  • Peptic ulcer bleeding
  • Use of antiplatelet and anticoagulant drugs
  • Urinary tract obstruction and urological abnormalities
  • History of renal abscess
  • Diabetes mellitus
  • Taking antibiotics in the previous two days
  • Catheterization two weeks ago
  • History of hospitalization or catheter in two weeks ago
  • Kidney stones

Outcomes

Primary Outcomes

Not specified

Similar Trials